Trials / Completed
CompletedNCT01588574
Study for Determine the Safety and Efficacy of Clostridium Botulinum Toxin Type A in Subjects With Cervical Dystonia
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Medy-Tox · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the Optimal dose for safety and efficacy in the treatment of cervical dystonia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | MT10109 | Botulinum toxin type A |
| BIOLOGICAL | BOTOX(Registered trade mark) | Botulinum toxin type A |
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2013-10-01
- Completion
- 2013-12-01
- First posted
- 2012-05-01
- Last updated
- 2014-09-08
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT01588574. Inclusion in this directory is not an endorsement.